Islet amyloid in recent-onset type 1 diabetes-the DiViD study

Ups J Med Sci. 2017 Aug;122(3):201-203. doi: 10.1080/03009734.2017.1359219. Epub 2017 Aug 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloid / metabolism*
  • Diabetes Mellitus, Type 1 / metabolism*
  • Diabetes Mellitus, Type 1 / pathology
  • Humans
  • Islets of Langerhans / metabolism*
  • Islets of Langerhans / pathology

Substances

  • Amyloid

Grant support

Supported by the Swedish Research Council (to G.T.W.), the Swedish Diabetes Foundation (to G.T.W.), and the Family Ernfors Foundation (to G.T.W). The DiViD study was funded by South-Eastern Norway Regional Health Authority (Grant to K.D.-J.), the Novo Nordisk Foundation (Grant to K.D.-J.), and through the PEVNET Study Group funded by the European Union’s Seventh Framework Programme (FP7/2007–2013) under grant agreement 261441 PEVNET.